The Formula for Oil Profits

Forward to a Friend Having trouble viewing this issue? Click here. Refer a Friend to Energy and Capital.

The Formula for Oil Profits By Jeff Siegel | Saturday, June 21st, 2014 This weekend, we bring you the week's most popular stories from Energy and Capital and our sister site, Wealth Daily... The Formula for Oil Profits: Beat Buy-and-Holders After five years of fine-tuning, this oil investment strategy has delivered a 97% accuracy rate, beating out the profits of ordinary investors by more than 50 times. And the next trade is coming... The Truth About Stem Cell Stocks: Why the Stem Cell Market is Soaring The opposition to stem cell research has drastically faded, and now the benefits of these treatments are becoming self-evident... Going Back to War: The Elite Think We Need Convincing Congress and media outlets seem to think it's high time we went back to war. But where has that gotten us in the past? Big Profits in Big Data: Who Will Win the Exabyte Game? If the trick to technology investing is getting in early on a big trend and riding the wave, we are in luck. This is a decade of big trends. Why the Vatican is Funding This Company: Revolutionary Heart Disease Therapy Makes Waves Stem cell therapy and the Vatican are widely known for being at odds. But the Vatican has provided this stem cell therapy company with $1 million. Find out why... Investing in Emerging Market Infrastructure: Morgan Stanley's (NYSE: MS) $22 Trillion Bet Morgan Stanley is predicting a $22 trillion investment in global infrastructure. Much of this will be focused on the world's rise of the megacity. Advertisement Put Your Money Where Your Country Is Right now, one company holds the key to a MASSIVE oil deposit right here in America... For now, shares trade for around $8, but I can't see that lasting much longer. You see, this company is sitting on a liquid gold mine that's bigger than five U.S. states combined. Conservatively speaking, I'm predicting easy 700% gains here. But I'll warn you... the faster you move, the more you stand to make. Check out the full scoop in this exclusive presentation. China's Golden Age of Gas: Exploiting China's Gas Greed Energy and Capital editor Keith Kohl tells readers how to take advantage of China's growing addiction to natural gas. Prepare for 300% Gains in 12 Months: This Tiny Biotech Has Big Pharma Talking A little-known biotech has a virtual monopoly over the coveted Blue Blood Protein... a vital component in hundreds of therapies for diseases ranging from cancer to Alzheimer's. Here's why it could surge 300% in the next year. 21 Billion Reasons West Texas is Booming: Conquering the Cline Shale Energy and Capital editor Keith Kohl takes a hard look at the $20.5 billion economic boost that the Cline Shale will bring to the West Texas economy. Investing in Metallic Glass: Changing the Nature of Metal Metal is one of the basic materials that have made human civilization possible. But now, in the second decade of the 21st century, the very nature of this ubiquitous class of materials is being changed — on a molecular level. Follow Energy and Capital on The Bottom Line Related Articles Biotech & Robotics Run Up Diversifying U.S. Oil Production U.S. Gas Exports OPEC's Oil Collapse Recently... Who Will Win the Exabyte Game? Buy Corn Now! Exploiting China's Gas Greed Why the Stem Cell Market is Soaring The Walls are Crumbling Around OPEC

This email was sent to ignoble.experiment@arconati.us . You can manage your subscription and get our privacy policy here. Energy and Capital, Copyright © 2014, Angel Publishing LLC, 111 Market Place #720, Baltimore, MD 21202. All rights reserved. No statement or expression of opinion, or any other matter herein, directly or indirectly, is an offer or the solicitation of an offer to buy or sell the securities or financial instruments mentioned. While we believe the sources of information to be reliable, we in no way represent or guarantee the accuracy of the statements made herein. Energy and Capital does not provide individual investment counseling, act as an investment advisor, or individually advocate the purchase or sale of any security or investment. Neither the publisher nor the editors are registered investment advisors. Subscribers should not view this publication as offering personalized legal or investment counseling. Investments recommended in this publication should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company in question. Unauthorized reproduction of this newsletter or its contents by Xerography, facsimile, or any other means is illegal and punishable by law. Please note: It is not our intention to send email to anyone who doesn't want it. If you're not sure why you're getting this e-letter, or no longer wish to receive it, get more info here, including our privacy policy and information on how to manage your subscription.